Development of new estrogen receptor-targeting therapeutic agents for tamoxifen-resistant breast cancer.

Jiang Q, Zheng S, Wang G. Development of new estrogen receptor-targeting therapeutic agents for tamoxifen-resistant breast cancer. Future Med Chem. 2013 Jun; 5(9):1023-35.

View in: PubMed

subject areas

Antineoplastic Agents, Hormonal
Apoptosis
Aromatase
Aromatase Inhibitors
Breast Neoplasms
Drug Resistance, Neoplasm
Estrogen Antagonists
Female
Humans
Receptors, Estrogen
Tamoxifen

authors with profiles

Guangdi Wang

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support